Fig. 4.

Effects of RTK inhibition on lung endothelial nitric oxide synthase (eNOS) activation, microvascular monocyte accumulation, and VEGF levels after CBDL. A: representative immunoblots and graphical summaries of protein levels for p-eNOS (Ser1177) in lung. B: immunofluorescence staining for ED1 (monocyte marker, red) in lung, and representative immunoblots and graphical summaries of lung ED1 and VEGF-A protein levels. Values are expressed as means ± SE (n = 8 animals for each group). *P < 0.05 compared with sham. ‡P < 0.05 compared with CBDL.